AngioLab Inc
251280
Company Profile
Business description
AngioLab Inc is a biotechnology company. It is developing pharmaceuticals and health functional foods based on the inhibition of angiogenesis. The group is developing natural products and antibody-based pharmaceuticals.
Contact
65, 122, 159, Techno 3-ro
Yuseong-gu
Gwanpyeong-dong, Hanshin S Mecca
Daejeon
KORT: +82 428675785
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
16
Stocks News & Analysis
stocks
The World Cup stock you’ve never heard of
This ASX stock is kicking goals at the FIFA World Cup.
stocks
Chart of the Week: Can WiseTech shares finally bounce back?
Market concerns over governance and AI fears have left shares trading well below the fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,003.70 | 34.90 | 0.39% |
| CAC 40 | 8,322.29 | 4.33 | -0.05% |
| DAX 40 | 25,068.40 | 49.87 | -0.20% |
| Dow JONES (US) | 52,635.50 | 148.09 | 0.28% |
| FTSE 100 | 10,499.77 | 27.32 | 0.26% |
| HKSE | 24,175.12 | 144.94 | 0.60% |
| NASDAQ | 26,208.88 | 1.99 | 0.01% |
| Nikkei 225 | 68,557.73 | 813.88 | 1.20% |
| NZX 50 Index | 13,785.67 | 120.49 | 0.88% |
| S&P 500 | 7,557.63 | 13.99 | 0.19% |
| S&P/ASX 200 | 8,806.00 | 38.20 | 0.44% |
| SSE Composite Index | 3,996.16 | 40.43 | -1.00% |